Using CRISPR to enhance T cell effector function for therapeutic applications-Reference-Cited by-同舟云学术

Using CRISPR to enhance T cell effector function for therapeutic applications

Published:2021-03 Issue:1 Volume:3 Page:100049
ISSN:2590-1532
Container-title:Cytokine: X
language:en
Short-container-title:Cytokine: X

Author:

Freen-van Heeren Julian J.

Publisher

Elsevier BV

Subject

Hematology,Molecular Biology,Immunology,Biochemistry,Immunology and Allergy

Reference165 articles.

1. High CD8+ and absence of Foxp3+ T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival;Fluxá;BMC Cancer.,2018

2. Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma;Ghatalia;J. Immunother. Cancer.,2019

3. T cell responses: naïve to memory and everything in between;Pennock;Adv. Psyiology Educ.,2013

4. Perforin and granzymes: function, dysfunction and human pathology;Voskoboinik;Nat. Rev. Immunol.,2015

5. Different subsets of T cells, memory, effector functions, and CAR-T immunotherapy;Golubovskaya;Cancers (Basel).,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining CRISPR with Flow‐FISH to study CRISPR‐mediated genome perturbation;Cytometry Part A;2023-12-09

2. Revolutionizing medicine with toll-like receptors: A path to strengthening cellular immunity;International Journal of Biological Macromolecules;2023-12

3. Clinical trials aimed at HIV cure or remission: new pathways and lessons learned;Expert Review of Anti-infective Therapy;2023-10-24

4. CAR-Based Therapy for Autoimmune Diseases: A Novel Powerful Option;Cells;2023-06-02

5. CLASH of the Titans: How CAR-T Cells Can Triumph Over Tumors;The CRISPR Journal;2023-04-01